Jeremy Levin’s Call to Action to Save American Biotech

A conversation with Jeremy Levin — physician-scientist, former Teva CEO, and author of Biotech and the Balance — on why America's biotech industry is at a strategic inflection point. Levin examines the forces undermining innovation: short-term capital structures mismatched to drug development timelines, eroding public trust in science and vaccines, and the hollowing out of NIH, FDA, and CDC. He outlines what bold leadership looks like in practice — defending facts, engaging patients, and treating biotech as national infrastructure before it's too late.